Mirabegron 67184-0571-02
- Manufacturer
- Qilu Pharmaceutical Co., Ltd.
- Dosage Form
- Tablet, Film Coated, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- June 30, 2025
- Listing Expires
- December 31, 2026
- Application
- ANDA217989
Need to source Mirabegron? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Mirabegron | 25 mg/1 |
Drug Class
beta3-Adrenergic Agonist [EPC]Adrenergic beta3-Agonists [MoA]Cytochrome P450 2D6 Inhibitors [MoA]
Selected Package
67184-0571-02Selected90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (67184-0571-2)
Other packages for this product(1)
30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (67184-0571-1)